Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
TY Zhu, LL Hong, ZQ Ling - Biomarker research, 2023 - Springer
Abstract N6-methyladenosine (m6A) is the most prevalent and well-characterized internal
chemical modification in eukaryotic RNA, influencing gene expression and phenotypic …
chemical modification in eukaryotic RNA, influencing gene expression and phenotypic …
Serum autoantibodies as biomarkers for early cancer detection
HT Tan, J Low, SG Lim, MCM Chung - The FEBS journal, 2009 - Wiley Online Library
Autoantibodies against autologus tumor‐associated antigens have been detected in the
asymptomatic stage of cancer and can thus serve as biomarkers for early cancer diagnosis …
asymptomatic stage of cancer and can thus serve as biomarkers for early cancer diagnosis …
The roles of insulin‐like growth factor 2 mRNA‐binding protein 2 in cancer and cancer stem cells
J Cao, Q Mu, H Huang - Stem cells international, 2018 - Wiley Online Library
RNA‐binding proteins (RBPs) mediate the localization, stability, and translation of the target
transcripts and fine‐tune the physiological functions of the proteins encoded. The insulin …
transcripts and fine‐tune the physiological functions of the proteins encoded. The insulin …
Serologic autoantibodies as diagnostic cancer biomarkers—a review
Current diagnostic techniques used for the early detection of cancers are successful but
subject to detection bias. A recent focus lies in the development of more accurate diagnostic …
subject to detection bias. A recent focus lies in the development of more accurate diagnostic …
Developments in point-of-care diagnostic technology for cancer detection
Cancer is the cause of death for one in seven individuals worldwide. It is widely
acknowledged that screening and early diagnosis are of vital importance for improving the …
acknowledged that screening and early diagnosis are of vital importance for improving the …
Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approaches
Autoantibodies produced by the patients' own immune systems in response to foreign
substances are emerging as an attractive biomarker for early detection of cancer. These …
substances are emerging as an attractive biomarker for early detection of cancer. These …
Role of miR-21 in the diagnosis of colorectal cancer: Meta-analysis and bioinformatics
J Li, H Chen, G Sun, X Zhang, H Ye, P Wang - Pathology-Research and …, 2023 - Elsevier
Advanced colorectal cancer (CRC) has a bad prognosis and is challenging to cure.
Therefore, there is an urgent need for an effective early diagnosis marker. MicroRNA-21 …
Therefore, there is an urgent need for an effective early diagnosis marker. MicroRNA-21 …
[HTML][HTML] IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers …
C Burdelski, N Jakani-Karimi… - Oncology …, 2018 - spandidos-publications.com
IMP3 is an RNA binding protein required for ribosomal RNA processing, which has been
suggested to be a prognostic marker in a large variety of human types of cancer. However …
suggested to be a prognostic marker in a large variety of human types of cancer. However …
Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer
Multiple studies have shown that cancer patients produce detectable autoantibodies against
certain tumor-associated antigens, which might be promising blood biomarkers for early …
certain tumor-associated antigens, which might be promising blood biomarkers for early …
Recent advances on immune targeted therapy of colorectal cancer using bi-specific antibodies and therapeutic vaccines
A Azadi, A Golchini, S Delazar… - Biological Procedures …, 2021 - Springer
Colorectal cancer (CRC) is a universal heterogeneous disease that is characterized by
genetic and epigenetic alterations. Immunotherapy using monoclonal antibodies (mAb) and …
genetic and epigenetic alterations. Immunotherapy using monoclonal antibodies (mAb) and …